SCHEMBL5264560

SCHEMBL5264560

Cc1ccc(Cl)cc1C1=CCN(Cc2[nH]n(Cc3ccc(F)cc3)c(=O)c2Cl)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKAB2 O43741 1/20 0.45
PRKAG1 P54619 1/20 0.45
PRKAA2 P54646 1/20 0.45
PRKAA1 Q13131 1/20 0.45
PRKAG3 Q9UGI9 1/20 0.45
PRKAG2 Q9UGJ0 1/20 0.45
PRKAB1 Q9Y478 1/20 0.45
MAPK1 P28482 1/20 0.41
NPSR1 Q6W5P4 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
KCNH2 Q12809 1/20 0.40
OPRM1 P35372 1/20 0.39
OPRK1 P41145 1/20 0.39
HTR6 P50406 4/20 0.38
DRD2 P14416 5/20 0.38
HTR1A P08908 3/20 0.38
SLC6A4 P31645 3/20 0.38
HTR7 P34969 3/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5267360 0.85 PRKAB2 (0.39) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3
SCHEMBL4328972 0.76 KCNH2 (0.43) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3
SCHEMBL2883013 0.70 CCNT1 (0.55) MAPK1NPSR1TDP1OPRM1OPRK1
SCHEMBL4341198 0.69 OPRM1 (0.43) OPRM1OPRK1HTR6DRD2HTR1A
SCHEMBL27712204 0.68 KDM4E (0.43) OPRM1OPRK1HTR6DRD2HTR1A
SCHEMBL5262822 0.67 MAPT (0.44) NPSR1MEN1KMT2A
SCHEMBL27712258 0.66 L3MBTL1 (0.37) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3
SCHEMBL4319914 0.66 PPARG (0.36) KCNH2OPRM1OPRK1DRD2
SCHEMBL4319927 0.66 LMNA (0.43) KCNH2MEN1KMT2AATMSIGMAR1
SCHEMBL4329500 0.65 L3MBTL1 (0.39) KCNH2HTR6DRD2HTR1ASLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1833800-A1 PYRAZOLONE COMPOUNDS AS METABOTROPIC GLUTAMATE RECEPTOR AGONISTS FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS AstraZeneca AB (SE) 2007-09-19 EP disclosed
WO-2006071730-A1 PYRAZOLONE COMPOUNDS AS METABOTROPIC GLUTAMATE RECEPTOR AGONISTS FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS ASTRAZENECA AB (SE) 2006-07-06 WO disclosed